[1] |
TRACY M K, BERKELHAMER S K. Bronchopulmonary dysplasia and pulmonary outcomes of prematurity[J]. Pediatr Ann, 2019, 48(4):e148-e153. doi:10.3928/19382359-20190325-03.
|
[2] |
GILFILLAN M, BHANDARI A, BHANDARI V. Diagnosis and management of bronchopulmonary dysplasia[J]. BMJ, 2021, 375: n1974. doi:10.1136/bmj.n1974.
|
[3] |
王一飞. 支气管肺发育不良诊断的变迁及临床实用性[J]. 中国小儿急救医学, 2022, 29(6):407-411.
|
|
WANG Y F. The history and clinical practicability of the diagnosis of bronchopulmonary dysplasia[J]. Chinese Pediatric Emergency Medicine, 2022, 29(6):407-411. doi:10.3760/cma.j.issn.1673-4912.2022.06.002.
|
[4] |
PRINCIPI N, DI PIETRO G M, ESPOSITO S. Bronchopulmonary dysplasia:clinical aspects and preventive and therapeutic strategies[J]. J Transl Med, 2018, 16(1):36. doi:10.1186/s12967-018-1417-7.
|
[5] |
LAUER T, BEHNKE J, OEHMKE F, et al. Bacterial colonization within the first six weeks of life and pulmonary outcome in preterm infants <1 000 g[J]. J Clin Med, 2020, 9(7):2240. doi:10.3390/jcm9072240.
|
[6] |
PAPAGIANIS P C, PILLOW J J, MOSS T J. Bronchopulmonary dysplasia:Pathophysiology and potential anti-inflammatory therapies[J]. Paediatr Respir Rev, 2019, 30:34-41. doi:10.1016/j.prrv.2018.07.007.
|
[7] |
KURATA H, OCHIAI M, INOUE H, et al. Inflammation in the neonatal period and intrauterine growth restriction aggravate bronchopulmonary dysplasia[J]. Pediatr Neonatol, 2019, 60(5):496-503. doi:10.1016/j.pedneo.2018.11.007.
|
[8] |
GALLACHER D, MITCHELL E, ALBER D, et al. Dissimilarity of the gut-lung axis and dysbiosis of the lower airways in ventilated preterm infants[J]. Eur Respir J, 2020, 55(5):1901909. doi:10.1183/13993003.01909-2019.
|
[9] |
HU J, BENNY P, WANG M, et al. Intrauterine growth restriction is associated with unique features of the reproductive microbiome[J]. Reprod Sci, 2021, 28(3):828-837. doi:10.1007/s43032-020-00374-5.
|
[10] |
BEETON M L, MAXWELL N C, DAVIES P L, et al. Role of pulmonary infection in the development of chronic lung disease of prematurity[J]. Eur Respir J, 2011, 37(6):1424-1430. doi:10.1183/09031936.00037810.
|
[11] |
TRAMPER J, ZHANG H, FOGLIA E E, et al. The association between positive tracheal aspirate cultures and adverse pulmonary outcomes in preterm infants with severe bronchopulmonary dysplasia[J]. Am J Perinatol, 2017, 34(1):96-104. doi:10.1055/s-0036-1584541.
|
[12] |
VAN KATWYK S, AUGUSTINE S, THéBAUD B, et al. Lifetime patient outcomes and healthcare utilization for Bronchopulmonary dysplasia (BPD) and extreme preterm infants: a microsimulation study[J]. BMC Pediatr, 2020, 20(1):136. doi:10.1186/s12887-020-02037-5.
|
[13] |
HYSINGER E, FRIEDMAN N, JENSEN E, et al. Bronchoscopy in neonates with severe bronchopulmonary dysplasia in the NICU[J]. J Perinatol, 2019, 39(2):263-268. doi:10.1038/s41372-018-0280-y.
|
[14] |
RAN X, HE Y, AI Q, et al. Effect of antibiotic-induced intestinal dysbacteriosis on bronchopulmonary dysplasia and related mechanisms[J]. J Transl Med, 2021, 19(1):155. doi:10.1186/s12967-021-02794-6.
|
[15] |
AGRAWAL S K, KHULLAR S, SRIVASTAVA A, et al. Corynebacterium striatum:An emerging nosocomial skin and soft-tissue pathogen[J]. Natl Med J India, 2021, 34(2):88-89. doi:10.4103/0970-258X.326750.
|
[16] |
SHARIFF M, ADITI A, BERI K. Corynebacterium striatum:An emerging respiratory pathogen[J]. J Infect Dev Ctries, 2018, 12(7):581-586. doi:10.3855/jidc.10406.
|